Insights

Rising demand for pharmaceutical and healthcare services in the Middle East is creating bountiful opportunities, ripe for Chinese companies with the expertise and ambition to seize them.

Iuiga found success by offering quality products at affordable, transparent prices. But it may need an extra edge to thrive in a more intricate market like China.

William Li, CEO of Nio, dedicated time to address 140 questions, delving into the company’s review of its recent performance and outlining its outlook for the next two years.

The market may be discontent with Tesla’s current phase of high investment, low output. But it may be an unavoidable stage to secure the company’s long-term success.

ByteDance is playing the long game by spending the year to refocus on business areas where it can leverage its strengths for long-term success.

ChaPanda is the next Chinese tea company seeking to go public. But can it navigate challenges that have troubled other brands, like Nayuki, which have ventured down a similar path?

Meituan is understandably cautious about venturing into international markets, but its declining market position may ultimately force its hand.

Manufacturing is the foundation of the automotive industry, with efficiency hinging on the strategies employed in this domain. Nio’s move to become independent exemplifies this principle.